References
- 1
Park C H, Lee S W, Kwon O S, et al.
The effects of anti-H. pylori therapy on development of endoscopic reflux esophagitis in peptic ulcer patients.
Gastrointest Endosc.
2000;
51
AB112
- 2
Rokkas T, Ladas S D, Triandafyllo C, et al.
Time trend for the appearance of esophagitis after Helicobacter pylori eradication.
Gastrointest Endosc.
2000;
51
AB110
- 3
Hayakawa T, Kaneko H, Funaki Y, et al.
Gastroesophageal pathophysiological factors affecting endoscopic findings in gastroesophageal
reflux disease (GERD).
Gastrointest Endosc.
2000;
51
AB111
- 4
Pandolfino J E, Kahrilas P J, DeVault K R, et al.
Comparison of inter- and intra-observer consistency of esophagitis grading by expert
and trainee endoscopists.
Gastrointest Endosc.
2000;
51
AB112
- 5
Earnest D, Bhattacharyyia A K, Rogriguez-Stanley S, et al.
Uncomplicated chronic heartburn: are biopsies necessary during screening endoscopy?.
Gastrointest Endosc.
2000;
51
AB116
- 6
Khaddari S SE, Damon H, Paulin C, et al.
Esophageal cytology by endoscopic brushing in the diagnosis of gastroesophageal reflux
disease (GERD) not complicated by esophagitis.
Gastrointest Endosc.
2000;
51
AB112
- 7
Jornod P, Dorta G o, Pantoflickova D, et al.
Peptic esophageal stricture: a vanishing complication of reflux esophagitis?.
Gastroenterology.
2000;
118
A484
- 8
Gardner J D, Rodriguez-Stanley S, Robinson M G.
Endoscopy-negative GERD is a gastric “hypersecretory” disorder.
Gastroenterology.
2000;
118
A482
- 9
Kato T, Naiki T, Onogi N, et al.
Is an esophageal dysfunction in PSS a most important contributive factor in severe
reflux esophagitis?.
Gastrointest Endosc.
2000;
51
AB111
- 10
Dahshan A H, Patel H, Delaney J, et al.
Gastroesophageal reflux and dental erosions in children.
Gastrointest Endosc.
2000;
51
AB113
- 11
Mahon D, Decadt B, Lowndes R, et al.
Prospective randomized trial of laparoscopic Nissen fundoplication (LNF) versus maintenance
proton-pump inhibition (PPI) in the treatment of gastroesophageal reflux disease (GERD)
in patients under 70 years old.
Gastroenterology.
2000;
118
A485
- 12
Lundell L, Miettinen P, Myrvold H, et al.
Continued (5 year) follow-up of a randomized clinical study comparing anti-reflux
surgery and omeprazole in gastroesophageal reflux disease.
Gastroenterology.
2000;
118
A191
- 13
DiRe C A, Jones M P, Kahrilas P J.
The economics of laparoscopic Nissen fundoplication (LNF): less drugs, same cost.
Gastroenterology.
2000;
118
A210
- 14
Spechler S, Lee E, Ahnen D, et al.
Long-term outcome of medical and surgical therapies for GERD: effects on survival.
Gastroenterology.
2000;
118
A489
- 15
Bammer T, Hinder R A, Klingler P J, et al.
Five to eight year outcome of the first laparoscopic Nissen fundoplications.
Gastroenterology.
2000;
118
A1061
- 16
Bammer T, Achem S R, DeVault K R, et al.
Use of acid suppressive medications after laparoscopic antireflux surgery: prevalence,
clinical indications and causes.
Gastroenterology.
2000;
118
A478
- 17
Fibbe C, Strate U, Emmermann A, et al.
Does preoperative esophageal dysmotility predict outcome after laparoscopic fundoplication
for GERD? A randomized, prospective trial.
Gastroenterology.
2000;
118
A481
- 18
Dehn T C, Smith G, Stratford J M.
Re-operation following laparoscopic fundoplication.
Gastroenterology.
2000;
118
A480
- 19
Blom D, Bowrey D J, Peters J H, et al.
The myth of dysphagia after antireflux surgery: analysis of swallowing difficulty
in patients with GERD.
Gastroenterology.
2000;
118
A1032
- 20
Booth M I, Stratford J M, Thompson E, et al.
Laparoscopic anti-reflux surgery is an effective treatment for the acid-sensitive
esophagus.
Gastroenterology.
2000;
118
A478
- 21
Fenton P, Terry M L, Galloway K D, et al.
Is there a role for laparoscopic fundoplication in patients with non-erosive reflux
disease (NERD)?.
Gastroenterology.
2000;
118
A481
- 22
Bell R C, Hanna P D, Brubaker S.
Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux.
Gastroenterology.
2000;
118
A1032
- 23
Hernandez E, Bahar R, Ament M, et al.
Outcome of laparoscopic Nissen fundoplication in neurologically normal children.
Gastroenterology.
2000;
118
A483
- 24
Kaminski A, Lord R V, Crookes P F, et al.
Lower esophageal sphincter residual pressure is related to dysphagia or recurrent
reflux after Nissen fundoplication.
Gastroenterology.
2000;
118
A1034
- 25
Heider T R, Farrell T M, Kircher S A, et al.
Complete fundoplication is not associated with increased dysphagia in patients with
abnormal esophageal motility.
Gastroenterology.
2000;
118
A1031
- 26
Salo J A, Rantanen T K, Makinen J, et al.
What is the clinical significance of esophageal histology after antireflux surgery?.
Gastroenterology.
2000;
118
A1031
- 27
Joubran R, Wilson M A, Wo J M.
Comparison between barium esophagram and upper endoscopy for the diagnostic evaluation
of postfundoplication symptoms.
Gastroenterology.
2000;
118
A484
- 28
Rothstein R I, Moodie K.
Depth of endoscopically placed sutures.
Gastrointest Endosc.
2000;
51
AB102
- 29
Filipi C J, Dunne D, Sweeney S, et al.
Endoscopic gastroesophageal suturing: does addition of cautery aid plication persistence?.
Gastrointest Endosc.
2000;
51
AB104
- 30
Swain P, Park P O, Kjellin T, et al.
Endoscopic gastroplasty for gastroesophageal reflux disease.
Gastrointest Endosc.
2000;
51
AB144
- 31
Filipi C J, Edmundowicz S A, Gostout C J, et al.
Transoral endoscopic suturing for gastroesophageal reflux disease: a multicenter trial.
Gastrointest Endosc.
2000;
51
AB143
- 32
Triadafilopoulous G, Utley D S, DiBaise J, et al.
Radiofrequency energy application to the gastroesophageal junction for the treatment
of gastroesophageal reflux disease.
Gastrointest Endosc.
2000;
51
AB223
- 33
DiBaise J K, Akromis I, Quigley E M.
Efficacy of radiofrequency energy delivery to the lower esophageal sphincter in the
treatment of GERD.
Gastrointest Endosc.
2000;
51
AB96
- 34 SEER Report. National Cancer Institute's surveillance, epidemiology and end results
program (public use CD-ROM). Bethesda, MD; National Cancer Institute, 1998
- 35
Lambert R.
The role of endoscopy in the prevention of digestive cancer: application to colorectal
cancer.
Endoscopy.
1998;
3
628-40
- 36
Lambert R.
The role of endoscopy in the prevention of esophagogastric cancer.
Endoscopy.
1999;
31
180-99
- 37
Eckardt V F, Bernhard G.
Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective
controlled investigation.
Gastrointest Endosc.
2000;
51
AB225
- 38
Conio M, Filiberti R, Blanchi S, et al.
Long-term endoscopic surveillance of patients with Barrett's esophagus: a prospective
study.
Gastroenterology.
2000;
118
A223
- 39
Zaman M S, Robson K, Rosenberg S, et al.
The development of dysplasia on follow-up endoscopy among patients with short-segment
Barrett's esophagus: a cohort of 61 patients followed for a mean of 30 months.
Gastrointest Endosc.
2000;
51
AB115
- 40
Hillman L C, Chiragakis L, Kaye G L, et al.
Significance of short-segment Barrett's esophagus.
Gastroenterology.
2000;
118
A222
- 41
Feldshon S D, Rodlund J L.
Barrett's esophagus: surveillance for short- and long-segment disease.
Gastrointest Endosc.
2000;
51
AB117
- 42
Pereira A D, Chaves P, Suspiro A, et al.
Incidence of high-grade dysplasia/adenocarcinoma in Barrett's esophagus: a prospective
study in a low-risk country for adenocarcinoma of the esophagus.
Gastroenterology.
2000;
118
A38
- 43
Rösch T, Allescher H D.
Digestive Diseases Week report, Orlando, May 1999.
Endoscopy.
1999;
31
768-827
- 44
Ott R, Rösch T, Muehlen J, et al.
Much ado about the “ultrashort” Barrett esophagus? Results from the Munich multicenter
study.
Gastrointest Endosc.
2000;
51
AB114
- 45
de Mas C R, Krämer M, Seifert E, et al.
Short Barrett: prevalence and risk factors.
Scand J Gastroenterol.
1999;
34
1065-1070
- 46
Morales T G.
The irregular Z-line in community practice: do we need to biopsy?.
Gastrointest Endosc.
2000;
51
AB115
- 47
Nandurkar S, Talley N J, Martin C J, et al.
Prevalence and associations of cardia epithelium.
Gastroenterology.
2000;
118
A226
- 48
El-Zimaity H M, Verghese V J, Ramchchatesingh J, et al.
The gastric cardia in gastroesophageal reflux disease.
Gastroenterology.
2000;
118
A480
- 49
Fass R, Sampliner R E, Spechler S J.
The relationship between esophageal acid exposure, dysplasia and extent of columnar
metaplasia in Barrett's esophagus.
Gastroenterology.
2000;
118
A685
- 50
Tharalson E F, Martinez S, Pulliam G, et al.
Correlation between the height of abnormal acid reflux and the length of Barrett's
esophagus.
Gastroenterology.
2000;
118
A230
- 51
Koek G H, Sifrim D, Lerut T, et al.
Esophagitis and Barrett's esophagus: acid reflux, bile reflux, or both?.
Gastroenterology.
2000;
118
A224
- 52
Pfaffenbach B, Orth K H, Langer M, et al.
Bile and acid reflux in short- and long-segment Barrett's esophagus, and in reflux
disease.
Gastroenterology.
2000;
118
A227
- 53
Menges M, Moeller M, Zeitz M.
Increased acid and bile reflux in patients with Barrett's esophagus compared with
reflux esophagitis: response to acid-suppressant therapy.
Gastroenterology.
2000;
118
A226
- 54
Bohmer C J, Hop W C, Meuwissen S G, et al.
Carcinoma of Barrett's esophagus: do smoking and alcohol really matter?.
Gastroenterology.
2000;
118
A459
- 55
Freedman J, Ye W, Naslund E, et al.
Increased risk of adenocarcinoma of the esophagus after cholecystectomy.
Gastroenterology.
2000;
118
A482
- 56
Abe Y, Ohara S, Sekine H, et al.
The effect of H. pylori infection in reflux esophagus and Barrett's esophagus.
Gastroenterology.
2000;
118
A221
- 57
Romero Y, Cameron A J, Burgart L J, et al.
Barrett's esophagus: a familial disorder?.
Gastroenterology.
2000;
118
A222
- 58
Sharma P, Kalahasthy K, Topalovski M ,.
Location of dysplasia and cancer in patients with Barrett's esophagus.
Gastroenterology.
2000;
118
A38
- 59
Chaves P, Pereira A D, Cruz C, et al.
Recurrence of columnar-lined esophagus segments (CLES) after surgery for Barrett's-associated
adenocarcinoma: the natural history of Barrett's esophagus.
Gastroenterology.
2000;
118
A222
- 60
Dresner S M, Lamb P J, Irving M, et al.
Adenocarcinoma arising in Barrett's esophagus: the impact of surveillance on stage
and outcome.
Gastroenterology.
2000;
118
A704
- 61
Lin O S, Mannava S, Hwang K L, et al.
Screening, surveillance and treatment practices for Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB114
- 62
Petraki K, Mantzaris G J, Petraki C, et al.
Immunohistochemical expression of cytokeratins 7 and 20 in gastric intestinal metaplasia
and in Barrett's esophagus.
Gastroenterology.
2000;
118
A226
- 63
Sharma P, Topalovski M, Weston A P, et al.
Cytokeratin 7 and 20 staining patterns in patients with cardia intestinal metaplasia
associated with either Barrett's esophagus or H. pylori.
Gastroenterology.
2000;
118
A229
- 64
Shearer C J, Going J J, MacKay C J, et al.
Patterns of cytokeratin 7 and 20 expression in esophageal and gastric intestinal metaplasia:
relationship to GERD.
Gastroenterology.
2000;
118
A229
- 65
Nandurkar S, Ormsby A H, Talley N J, et al.
Short-segment Barrett's or not: cytokeratin (CK) 7/20 immunoreactivity could be the
key.
Gastroenterology.
2000;
118
A226
- 66
Pace F, Pallotta S, Foschi D, et al.
Absence of distinctive cells in the squamocolumnar junction of patients with Barrett's
esophagus (BE): an ultramicroscopic study.
Gastroenterology.
2000;
118
A227
- 67
Moerk H, Scheurlen M, Al-Taie O, et al.
Characterization of Barrett's and regenerative squamous mucosa by MUC1 and MUC2 mRNA expression.
Gastroenterology.
2000;
118
A226
- 68
Dutta S K, Choi Y L, Lagerholm S, et al.
Evidence for enhanced expression of telomerase activity in patients with Barrett's
esophagus with dysplasia and adenocarcinoma.
Gastroenterology.
2000;
118
A707
- 69
Morris C D, Bigley G, Armstrong G R, et al.
Expression of cyclooxygenase-2 (COX-2) in Barrett's esophagus, dysplasia and adenocarcinoma.
Gastroenterology.
2000;
118
A685
- 70
Robert M E, Washington M K, Lee J R, et al.
Diagnosis of dysplasia in Barrett's esophagus by immunohistochemistry of nuclear proliferation
(P53) and cellular trafficking (RAB 11).
Gastroenterology.
2000;
118
A228
- 71
Jost C, Lewin D N, Mulcahy H E, et al.
Do gastroesophageal reflux-induced changes in the squamous mucosa have a positive
association with the presence of the intestinal metaplasia of Barrett's esophagus?.
Gastrointest Endosc.
2000;
51
AB117
- 72
Madsen J A, Mitros F A.
Interobserver variability of Barrett esophagus related to gastrointestinal pathology
training.
Gastroenterology.
2000;
118
A225
- 73
Ormsby A H, Petras R E, Henricks W H, et al.
Interobserver variation in Barrett's (BE)-related high-grade dysplasia (HGD) and superficial
adenocarcinoma: can it be improved using uniform pathologic criteria?.
Gastroenterology.
2000;
118
A686
- 74
Jost C, Lewin D N, Mulcahy H E, et al.
Toward the development of databases on Barrett's esophagus: the variability of routine
histopathological reporting on biopsies in patients with suspected Barrett's requires
a systematic review for consistent data collection.
Gastrointest Endosc.
2000;
51
AB116
- 75
Buttar N S, Wang K S, Krishnadath K K, et al.
Digital image analysis is highly sensitive and specific in differentiating high- from
low-grade dysplasia in Barrett's esophagus.
Gastroenterology.
2000;
118
A684
- 76
Saeian K, Staff D, Townsend W, et al.
Detection rate of dysplastic Barrett's mucosa by unsedated transnasal endoscopy (T-EGD)
is comparable to conventional endoscopy.
Gastroenterology.
2000;
118
A228
- 77
Wo J M, Ray M B, Mayfield-Stokes S, et al.
Diagnostic benefit of methylene blue-directed biopsy compared to conventional biopsy
for the diagnosis of intestinal metaplasia and dysplasia in Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB113
- 78
Tonelotto E B, Torresini R S, Coelho N V, et al.
Magnifying endoscopy can make the diagnosis of specialized intestinal metaplasia at
the esophagogastric junction.
Gastrointest Endosc.
2000;
51
AB117
- 79
Guelrud M, Herrera I, Castro J, et al.
Enhanced magnification endoscopy: a new technique to identify specialized intestinal
metaplasia in Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB91
- 80
Sueoka N, Nisigaki H, Yonezawa M, et al.
Usefulness of double dye staining (methylene blue and crystal violet) for the magnifying
observation of intestinal metaplasia in Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB117
- 81
Das A, Sivak J R, et al.
MV, Chak A, et al. Role of high-resolution endoscopic imaging using optical coherence
tomography (OCT) in patients with Barrett's esophagus (BE).
Gastrointest Endosc.
2000;
51
AB93
- 82
Poneros J M, Brand S, Bouma B E, et al.
Diagnosis of specialized intestinal metaplasia by optical coherence tomography.
Gastrointest Endosc.
2000;
51
AB226
- 83
Seitz U.
In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus,
and adenocarcinoma of the esophagus.
Gastrointest Endosc.
2000;
51
AB94
- 84
Gonzalez-Correa C A, Brown B H, Smallwood R H, et al.
Towards the diagnosis of Barrett's esophagus by electric virtual biopsies.
Gastroenterology.
2000;
118
A223
- 85
Egger K, Rösch T, Allescher H D, et al.
Video endoscopy and stepwise biopsy of Barrett's esophagus are still necessary despite
sophisticated diagnostic methods.
Gastrointest Endosc.
2000;
51
AB115
- 86
Sontag S J, Schnell T G, Chejfec G.
Prevalence and incidence of ADCA in Barrett's with flat mucosa and in Barrett's with
teeny-weeny bumps: don't be so cocky.
Gastroenterology.
2000;
118
A720
- 87
Gossner L, May A, Pech O, et al.
Chromoendoscopy for the detection of dysplasia or mucosal cancer in Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB120
- 88
Banerjee B, Agarwal S, Jonnalagada S, et al.
Use of shorter wavelength autofluorescence band in Barrett's esophagus: effect of
dysplasia and inflammation.
Gastrointest Endosc.
2000;
51
AB115
- 89
Saidi R, Wong Kee Song L M, DaCosta R, et al.
Fluorescence studies of the selectivity of 5-aminolevulinic acid-induced protoporphyrin
IX in Barrett's esophagus.
Gastroenterology.
2000;
118
A230
- 90
Brand S A, Wang T D, Schomacker K T, et al.
Detection of high-grade dysplasia in Barrett's esophagus by 5-aminolevulinic acid
(ALA)-induced protoporphyrin IX (PPIX) fluorescence spectroscopy.
Gastroenterology.
2000;
118
A193
- 91
Jornod P, Stepinac T, Lange N, et al.
Barrett's esophagus: high detection rate for dysplasia and early adenocarcinoma by
combined screening with 4-quadrant biopsies and photodynamic detection.
Gastroenterology.
2000;
118
A685
- 92
Wong Kee Song L M, Shim G M, Wilson B C, et al.
Identifying dysplasia within Barrett's esophagus using Raman spectroscopy.
Gastrointest Endosc.
2000;
51
AB226
- 93
Lovat L B, Pickard D, Novelli M, et al.
A novel optical biopsy technique using elastic scattering spectroscopy for dysplasia
and cancer in Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB227
- 94
May A D, Pech O, Gossner L, et al.
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's
esophagus.
Gastrointest Endosc.
2000;
51
AB114
- 95
Wang K K, Buttar N S, Lutzke L S, et al.
Long-term results of photodynamic therapy for Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB225
- 96
Wolfsen H C, Woodward T A.
Photodynamic therapy for dysplastic Barrett's esophagus and mucosal esophageal adenocarcinoma:
the value of endoscopic ultrasound and results using the bare fiber technique.
Gastrointest Endosc.
2000;
51
AB116
- 97
Nijhawan P K, Wolfsen H, Wand K K, et al.
Cutaneous photosensitivity after photodynamic therapy: is it really more common in
sunny climates?.
Gastroenterology.
2000;
118
A227
- 98
Buttar N S, Nijhawan P K, Krishnadath K K, et al.
Combined endoscopic mucosal resection (EMR) and photodynamic therapy (PDT) for esophageal
neoplasia within Barrett's esophagus.
Gastroenterology.
2000;
118
A35
- 99
Spinelli P, Conio M, Mancini A, et al.
The association of endoscopic mucosal resection and photodynamic therapy in the treatment
of nodular dysplastic areas arising in Barrett's esophagus.
Gastrointest Endosc.
2000;
51
AB103
- 100
Tigges H, Fuchs K H, Maroske J, et al.
Combination of endoscopic argon plasma coagulation (EACP) and antireflux surgery for
treatment of Barrett's esophagus.
Gastroenterology.
2000;
118
A1058
- 101
Hafner S G, Straub T K, Wehrmann M, et al.
Experimental results for a new strategy to treat Barrett's esophagus: an in-vitro
study by using endoscopic high-frequency ultrasound.
Gastrointest Endosc.
2000;
51
AB113
T. Rösch,M.D.
Dept. of Internal Medicine II Klinikum rechts der Isar Technical University of Munich
Ismaninger Strasse 22 81675 München Germany
Fax: Fax:+ 49-89-4140-4872 or + 49-89-4141-9245
eMail: E-mail:Thomas.Roesch@lrz.tu-muenchen.de
